Clinical Trials on Eluted Swab

Total 49637 results

Real Prevention, LLC
Indiana University

Completed

Developing and Testing the Opioid Rapid Response System

Opioid Overdose

United States
Boston Medical Center
Substance Abuse and Mental Health Services Administration (SAMHSA)

Terminated

Response to Relapse in Office-Based Opioid Treatment Trial (RR-OBOT)

Opioid-use Disorder

United States
Alar Pharmaceuticals Inc.

Completed

Single Ascending Dose Study of ALA-1000

Opioid-use Disorder

United States
New York State Psychiatric Institute
USWM, LLC (dba US WorldMeds)

Completed

Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment

Opioid-use Disorder

United States
University of Maryland, Baltimore

Withdrawn

Safety and Preliminary Efficacy of ANS-6637 to Reduce Drug Craving and Harm in People With Opioid Use Disorder (SEARCH)

Opioid-use Disorder
University of Virginia

Unknown

Utilizing Helpline for Opioid Dependence Treatment

Opioid Dependence

United States
University of Wisconsin, Madison
National Institute on Drug Abuse (NIDA)

Completed

Intervention to Expand Opioid Use Disorder Treatment Pharmacotherapy Prescribers

Opioid-use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Intranasal Naltrexone and Naloxone

Opioid-use Disorder
Yale University
National Institute on Drug Abuse (NIDA); VA Connecticut Healthcare System

Completed

Disulfiram for Cocaine-Alcohol Abuse - 3

Alcohol-Related Disorders | Cocaine-Related Disorders

United States
Member Companies of the Opioid PMR Consortium
Kaiser Permanente; World Health Information Science Consultants, LLC

Completed

Study to Validate Coded Medical Terms Used to Identify Opioid-Related Overdose in Databases Used for PMR Study 1B

Opioid-Related Disorders | Drug Abuse | Opiate Addiction | Narcotic Abuse
Stony Brook University

Withdrawn

Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology

Opioid-use Disorder
University of California, Los Angeles
Alkermes, Inc.

Completed

Injectable Pharmacotherapy for Opioid Use Disorders (IPOD) (IPOD)

Opioid Use Disorders

United States
Braeburn Pharmaceuticals

Completed

Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence

Opioid Use Disorders

United States
University of California, San Francisco
San Francisco Veterans Affairs Medical Center

Completed

Methadone Oxytocin Option (MOO)

Opioid Dependence | Substance Abuse | Methadone Treatment

United States
University of Vermont

Unknown

Interim Buprenorphine Treatment to Bridge Waitlist Delays: Stage II Evaluation

Opioid-use Disorder

United States
University of Michigan
Centers for Disease Control and Prevention

Completed

Safety & Prevention Outcomes Study (SPOS)

Opioid-Related Disorders | Drug Overdose

United States
Butler Hospital
Boston Medical Center

Completed

Linking Hospitalized Injection Drug Users to Buprenorphine

Opiate Dependence

United States
The Miriam Hospital

Completed

Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1

HIV Prevention | Opioid-Related Disorders

United States
University of Arkansas
National Institute on Drug Abuse (NIDA)

Completed

Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals (Detox)

Opioid Dependence | Opioid Withdrawal | Opioid Detoxification

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown

Study of Opioid Immunosuppressive Effects

Opioid Abuse or Dependence
University of Vermont Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Effective Treatment for Prescription Opioid Abuse

Prescription Opioid Dependence

United States
Seattle Institute for Biomedical and Clinical Research
Abbott

Completed

Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms

Alcoholism | Mood Disorders | Alcohol Related Disorders

United States
Portland VA Research Foundation, Inc
Steven & Alexandra Cohen Foundation

Recruiting

Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

Amphetamine-Related Disorders

United States
VA Office of Research and Development

Recruiting

Impact of Work Activity on SUD Outcomes

Substance-related Disorders

United States
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Recruiting

Neurocircuit Strategy to Decrease Cocaine Cue Reactivity (COCA)

Cocaine-Related Disorders

United States
Finnish Institute for Health and Welfare
Social Insurance Institution, Finland

Active, not recruiting

Socioeconomic Differences in Alcohol Harm in Finland in a Nationwide Cohort Study

Alcohol-Related Disorders
The University of Texas Health Science Center,...

Completed

Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention

Cocaine-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene...

Completed

Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2

Cocaine-Related Disorders

United States
Dartmouth-Hitchcock Medical Center
National Institute on Drug Abuse (NIDA); Johns Hopkins University; Dartmouth... and other collaborators

Completed

Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network (AutoSense)

Cocaine-Related Disorders

United States
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Completed

Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo

Cocaine-Related Disorders

United States
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals

Cocaine-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA); VA Connecticut Healthcare System

Completed

Glutaminergic Agents for Cocaine Abuse - 5

Cocaine-Related Disorders

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Withdrawn

Piracetam for Treatment of Cocaine Addiction, Phase II - 4

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Washington D.C. Veterans Affairs Medical Center

Completed

Evaluation of Benztropine for Cocaine Craving - 2

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Selegiline in Outpatient Treatment for Cocaine Dependence - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Cincinnati MDRU

Completed

Cocaine-Methylphendidate Interaction Study - 4

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Propranolol for Treatment of Cocaine Addiction - 2

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Ondansetron for the Treatment of Methamphetamine Dependence - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Dextroamphetamine-Cocaine Behavioral Intervention - 5

Cocaine-Related Disorders

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Completed

Pharmacological Modulation of Cocaine Effects - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Columbia University

Completed

Cocaine Effects in Humans: Physiology and Behavior - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Bupropion for the Treatment of Methamphetamine Dependence - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Completed

Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Effects of Fatty Acid Supplementation on Substance Dependent Individuals

Substance-related Disorders
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Baclofen for the Treatment of Cocaine Dependence - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Minnesota

Completed

Effects of Carvedilol on Cocaine Use in Humans - 11

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Interaction Between Cocaine and Quetiapine - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of Potential Interactions Between Cocaine and Tolcapone - 1

Cocaine-Related Disorders

United States

Clinical Trials on Eluted Swab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations